Dextroamphetamine will show up as a positive result on virtually every standard drug test that screens for amphetamines. It is, after all, amphetamine — the “dextro” prefix just specifies which mirror-image form of the molecule it is. Whether you take it as a standalone prescription (Dexedrine), as part of a mixed-amphetamine product, or as the active metabolite of lisdexamfetamine (Vyvanse), the drug appears in urine, oral fluid, and hair samples using routine testing methods. What gets more interesting, and what actually matters to most people asking this question, is how that positive result is handled once it appears.
Why Dextroamphetamine Triggers a Positive Screen
The first step in most drug-testing programs is an immunoassay, a quick and relatively cheap screening test. These tests use antibodies designed to bind to amphetamine and structurally similar molecules. Dextroamphetamine fits that antibody perfectly, so it reliably triggers a positive result. Several commercial immunoassay platforms exist, and they all catch dextroamphetamine at standard cutoff levels.1PubMed. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing Point-of-care cup tests used in clinics and emergency departments work the same way, with overall sensitivity for amphetamines above 97% in comparative studies.2PubMed. Comparative Analyses of Three Point-of-Care Urine Drug Test Devices’ Performance Characteristics for Use in Ambulatory Clinic Settings
The screening cutoff for amphetamines in federally regulated workplace testing is 500 ng/mL for urine (lowered from a previous 1,000 ng/mL standard). At the older, higher cutoff, a single low dose of dextroamphetamine could actually slip under the radar. In one study, only about 19% of urine specimens collected after a single 5 mg dose screened positive at a 1,000 ng/mL cutoff, while roughly 88% were positive after a 20 mg dose.1PubMed. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing Peak urine concentrations after that small 5 mg dose ranged from about 620 to 3,160 ng/mL, meaning some people barely produced enough to cross the threshold, while others sailed over it. At the lower cutoffs now commonly used, though, even modest therapeutic doses are far more likely to trigger a positive.
How Long It Stays Detectable
A study of healthy volunteers given a single therapeutic dose found that amphetamine was detectable in urine for a median of about 78 hours after a 10 mg dextroamphetamine dose, and about 77 hours after a 30 mg lisdexamfetamine dose. In oral fluid, the numbers were similar: roughly 69 hours for dextroamphetamine and 67 hours for lisdexamfetamine.3PubMed Central. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers That is about three days of detectability from a single dose.
For people taking dextroamphetamine daily, the picture changes. Repeated dosing means the drug accumulates to some extent, so the detection window after your last dose is likely to stretch longer than what a single-dose study shows. Urine pH also plays a role: more acidic urine speeds up the excretion of amphetamine, while more alkaline urine slows it down and can extend detection. Alkalizing agents, whether from diet or supplements, can prolong exposure to dextroamphetamine by slowing its clearance.3PubMed Central. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers
Hair testing is a different animal entirely. Dextroamphetamine does get incorporated into hair, which means it can be detected in a standard hair segment covering roughly the past 90 days. One study confirmed that d-amphetamine was found in all hair samples from patients taking lisdexamfetamine. However, the concentrations varied so widely between individuals that hair testing could confirm someone had used the drug but could not reliably measure how much or how often.4PubMed Central. Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine
What Happens After the Screen Is Positive
A positive immunoassay screen is not the final word. In most regulated testing programs, a positive screen gets sent for confirmatory testing using more sophisticated analytical methods. The gold standards are gas chromatography–mass spectrometry (GC-MS) and liquid chromatography–tandem mass spectrometry (LC-MS/MS), both of which can identify specific drugs rather than just drug classes. A multi-laboratory comparison found that LC-MS/MS performed at least as well as GC-MS in terms of precision, accuracy, and specificity for amphetamine and related compounds.5Oxford Academic Journal of Analytical Toxicology. A comparison of the validity of gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry analysis of urine samples II
These confirmatory tests will identify the substance as amphetamine. They will not, on their own, tell you whether it came from a prescription or from illicit use. For that, you need one more step.
How Labs Can Tell Prescription Use From Illicit Use
This is the part most people with a legitimate prescription care about. Amphetamine exists in two mirror-image forms: d-amphetamine (dextroamphetamine, the one in most ADHD medications) and l-amphetamine (levoamphetamine, a less potent form). Illicit methamphetamine, when it breaks down in the body, produces a racemic mixture of both d-amphetamine and l-amphetamine. Prescription dextroamphetamine, by contrast, produces overwhelmingly d-amphetamine with very little of the l-form.
Specialized chiral analysis can separate these two forms and measure their relative proportions. A large-scale evaluation of over 24,000 chiral amphetamine test results spanning a decade found that reporting the percentage of l-amphetamine relative to total amphetamine was a useful tool for distinguishing ADHD medication adherence from illicit drug use.6PubMed Central. Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023 Enantiomer-specific testing can be performed in urine, oral fluid, and blood using chiral chromatographic columns.7Journal of Analytical Toxicology. Enantiomer-specific analysis of amphetamine in urine, oral fluid and blood
Not every testing program performs chiral analysis by default. Standard workplace panels often stop at confirming the presence of amphetamine. But when the distinction matters, such as in pain-management clinics, addiction treatment, or military testing, the technology exists to make it reliably. In one study examining Vicks VapoInhaler (which contains l-methamphetamine), researchers confirmed that no d-methamphetamine or d-amphetamine was found in any urine specimen from people using the inhaler, making it straightforward to separate from prescription dextroamphetamine use.8PubMed Central. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration
The Medical Review Officer Step
In U.S. federally regulated drug testing and in many private-employer programs, a confirmed positive result goes to a Medical Review Officer (MRO) before any action is taken. The MRO is a licensed physician whose job is to determine whether there is a legitimate medical explanation for the result. If you have a prescription for dextroamphetamine, the MRO will verify it and report the test as “negative” to your employer.
A retrospective analysis of nearly 70,000 MRO evaluations in the U.S. Army from 2009 through 2012 showed that the majority of positive results were associated with authorized prescriptions. However, the same analysis flagged significant abuse of both oxycodone and d-amphetamine, meaning that some positive results were from people using these drugs without a valid prescription.9PubMed. Unauthorized drug use in the US Army based on medical review officer evaluations The MRO process is designed to handle exactly this situation, but it only works if you can produce documentation of your prescription. If your test is coming up and you take dextroamphetamine, make sure you have your prescription information readily available.
Lisdexamfetamine and Other Prodrugs
Lisdexamfetamine (Vyvanse) is a prodrug, meaning it is pharmacologically inactive until your body converts it. After you swallow it, enzymes in red blood cells cleave the lysine amino acid from the molecule, releasing pure d-amphetamine.10PubMed Central. Detection of lisdexamfetamine and its metabolite d-amphetamine in urine and gastric contents collected from a cadaver at forensic autopsy On a drug test, lisdexamfetamine looks identical to dextroamphetamine. The confirmatory test will report amphetamine, and the same MRO verification process applies.
Lisdexamfetamine is not the only prodrug that metabolizes into amphetamine. Certain weight-loss drugs marketed outside the United States, such as clobenzorex, also produce amphetamine as a metabolite. This has caught people off guard during drug testing, particularly individuals who purchased weight-loss products abroad.11Journal of Forensic Sciences. Metabolic Production of Amphetamine Following Administration of Clobenzorex If you are taking any medication that you obtained internationally, it is worth checking whether it has an amphetamine-class metabolite before you face a drug test.
Medications That Can Mimic Amphetamine on a Screen
Immunoassay screens are designed to cast a wide net, and that net sometimes catches molecules that look structurally similar to amphetamine but are not. A range of prescription and over-the-counter medications have been documented to produce false-positive amphetamine results. Among the prescription drugs reported to cause this are fluoxetine, selegiline, trazodone, chlorpromazine, promethazine, and labetalol. Over-the-counter culprits include nasal decongestants containing pseudoephedrine or phenylpropanolamine, and Vicks inhalers.12PubMed Central. Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
More recently, solriamfetol (a medication for excessive sleepiness) and m-chlorophenylpiperazine (the main metabolite of trazodone) were shown to cause false-positive amphetamine results on at least one commercial immunoassay platform.13PubMed. Solriamfetol and m-chlorophenylpiperazine cause false positive amphetamine results on urine drug screening The key word here is “false positive” — these are not amphetamines, and confirmatory testing by GC-MS or LC-MS/MS will correctly identify them as negative for amphetamine. If you are taking dextroamphetamine with a valid prescription, this issue is largely academic for you, since your test will be truly positive, not falsely positive. But it is useful context for understanding why the two-step testing process exists.
When a Low Dose Might Not Show Up
There is an ironic edge case worth knowing about. If you are prescribed a very low dose of dextroamphetamine, your urine concentration might not reliably exceed the screening cutoff. As noted earlier, a single 5 mg dose only produced positive screens in about one in five specimens at the old 1,000 ng/mL cutoff. Even peak urine levels for that dose ranged widely, from about 620 to 3,160 ng/mL.1PubMed. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing At a 10 mg dose, about two-thirds of specimens were positive. At 20 mg, nearly all were.
This matters in two scenarios. First, if a testing program is trying to verify that you are actually taking your prescribed medication (common in addiction treatment or pain management), a very low dose might produce a negative screen even though you are compliant. Second, a person’s hydration level, body composition, metabolism, and urine pH all influence how much drug ends up in any given sample. Two people taking the same dose might produce quite different urine concentrations.
Sample Handling and Pre-Analytical Factors
Once a urine sample leaves your body, its story is not over. How the sample is stored, transported, and processed can influence the measured drug concentration. Temperature, pH shifts during transport, and even the material of the collection container can alter results. For amphetamines specifically, these pre-analytical factors tend to be less dramatic than for some other drug classes (cannabinoids are more finicky), but labs still need to control for them to get accurate numbers.14Journal of Analytical Toxicology. Pre-analytical stability of drugs of abuse in urine for confirmatory testing: a systematic review Elevated temperatures can also lower creatinine concentrations in the sample, which matters because creatinine is the standard measure labs use to check whether a sample is too dilute to be valid.
Genetic Variation in How You Metabolize Amphetamine
Not everyone processes amphetamine at the same speed. A key liver enzyme, CYP2D6, is involved in the metabolism of amphetamine, and genetic variation in the gene coding for this enzyme is surprisingly common. Some people are “poor metabolizers” who break the drug down slowly, and others are “ultrarapid metabolizers” who clear it faster than average. Research has explored using the ratio of amphetamine to its metabolites in urine as a way to categorize a person’s CYP2D6 activity.15PubMed Central. Categorization of Cytochrome P4502D6 Activity Score by Urinary Amphetamine/Methamphetamine Ratios
From a drug-testing perspective, this genetic variability means two things. Slow metabolizers may have the drug detectable in their system for longer than average after their last dose. Rapid metabolizers might clear it faster, potentially dropping below the detection threshold sooner. Neither scenario changes whether the drug will show up on a test taken within the normal detection window, but it does affect the margins, especially for people on low doses or at the tail end of the detection period.
Oral Fluid Testing and Why It Is Growing
Oral fluid (saliva) testing has gained traction as an alternative to urine, particularly for roadside testing and workplace programs that want observed collection without the logistical awkwardness of urine collection. For dextroamphetamine, the detection window in oral fluid is roughly comparable to urine. In the controlled study of healthy volunteers, amphetamine was detectable in oral fluid for a median of about 69 hours after a single dextroamphetamine dose, compared to about 78 hours in urine.3PubMed Central. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers
Oral fluid has some practical advantages: collection is simpler, harder to adulterate, and can be done under direct observation without privacy concerns. But it also has quirks. Amphetamine is a basic drug, so its concentration in saliva can be higher than in plasma, especially shortly after dosing, because basic drugs tend to accumulate in the slightly acidic environment of the mouth. This means oral fluid tests can be quite sensitive in the hours immediately following a dose.
Practical Advice for People With a Prescription
If you are prescribed dextroamphetamine or lisdexamfetamine and face a drug test, the single most important step is documentation. Keep a copy of your prescription, or at minimum know your prescribing doctor’s name and pharmacy. In any testing program with an MRO, disclosing your prescription after a confirmed positive result is how the result gets reclassified.
Some people worry about disclosing a psychiatric medication to an employer. In most regulated testing frameworks, the MRO reports only “positive” or “negative” to the employer, not the specific drug or the medical reason for it. The details of your prescription stay between you and the MRO. That said, not every employer follows federal guidelines perfectly, and unregulated workplace tests (the kind done at walk-in clinics for small employers) sometimes skip the MRO step entirely and hand raw results to whoever ordered the test. If you are unsure about the process your employer uses, ask the testing company before the test what happens if a prescription medication causes a positive result.
For people enrolled in addiction treatment programs, the situation can be more complicated. These programs sometimes require disclosure of all medications, and the presence of d-amphetamine in a urine specimen, even from a legitimate ADHD prescription, needs to be communicated in advance to avoid misunderstandings. The chiral analysis tools described earlier are increasingly used in clinical settings to verify that a patient’s amphetamine-positive result matches the expected pattern for their prescription rather than illicit methamphetamine use.